Advanced search
Publication Cover
Autoimmunity Volume 38, 2005 - Issue 7
Submit an article Journal homepage
249
Views
51
CrossRef citations to date
0
Altmetric
Original

Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus

Gunnel Nordmark University Hospital, Department of Medical Sciences, Section of Rheumatology, Uppsala, Sweden
,
Christine Bengtsson University Hospital, Department of Rheumatology, Lund, Sweden
,
Anders Larsson University Hospital, Department of Medical Sciences, Section of Clinical Chemistry, Uppsala, Sweden
,
F. Anders Karlsson University Hospital, Department of Medical Sciences, Section of Endocrinology, Uppsala, Sweden
,
Gunnar Sturfelt University Hospital, Department of Rheumatology, Lund, Sweden
&
Lars Rönnblom University Hospital, Department of Medical Sciences, Section of Rheumatology, Uppsala, Sweden
Pages 531-540 | Published online: 07 Jul 2009

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

J. M. Soares-Jr, I. C. Espósito Sorpreso, J. F. Nunes Curado, E. S. Ferreira Filho, R. dos Santos Simões, E. Bonfá, C. A. Silva & E. C. Baracat. (2022) Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review. Climacteric 25:5, pages 427-433.
Read now
Jamal Mikdashi. (2018) Measuring and monitoring health-related quality of life responsiveness in systemic lupus erythematosus patients: current perspectives. Patient Related Outcome Measures 9, pages 339-343.
Read now
Claudia Elera-Fitzcarrald, Alejandro Fuentes, Luis Alonso González, Paula I. Burgos, Graciela S. Alarcón & Manuel F. Ugarte-Gil. (2018) Factors affecting quality of life in patients with systemic lupus erythematosus: important considerations and potential interventions. Expert Review of Clinical Immunology 14:11, pages 915-931.
Read now
C. Peixoto, C. G. Carrilho, J. A. Barros, T. T. S. B. Ribeiro, L. M. Silva, A. E. Nardi, A. Cardoso & A. B. Veras. (2017) The effects of dehydroepiandrosterone on sexual function: a systematic review. Climacteric 20:2, pages 129-137.
Read now
MWP Tsang-A-Sjoe & IEM Bultink. (2015) Systemic lupus erythematosus: review of synthetic drugs. Expert Opinion on Pharmacotherapy 16:18, pages 2793-2806.
Read now
Hon K Yuen & Melissa A Cunningham. (2014) Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review. Therapeutics and Clinical Risk Management 10, pages 775-786.
Read now

Articles from other publishers (45)

Parth Jethwani, Ashu Rastogi & Ravindra Shukla. (2023) Dehydroepiandrosterone sulfate supplementation in health and diseases. World Journal of Meta-Analysis 11:4, pages 102-111.
Crossref
Pantelis Baniotopoulos, Nikolaos Pyrgidis, Ioanna Minopoulou, Maksim Tishukov, Ioannis Sokolakis, Georgios Hatzichristodoulou & Theodoros Dimitroulas. (2022) Treatment of Sexual Dysfunction in Women with Systemic Autoimmune Rheumatic Disorders: A Systematic Review. Sexual Medicine Reviews 10:4, pages 520-528.
Crossref
Oliver Skoglund, Tomas Walhelm, Ingrid Thyberg, Per Eriksson & Christopher Sjöwall. (2022) Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes. Journal of Clinical Medicine 11:18, pages 5300.
Crossref
Thomas P. Walsh, Grayson L. Baird, Michael K. Atalay, Saurabh Agarwal, Daniel Arcuri, James R. Klinger, Christopher J. Mullin, Heather Morreo, Brynn Normandin, Sruti Shiva, Mary Whittenhall & Corey E. Ventetuolo. (2021) Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial. Pulmonary Circulation 11:2, pages 1-9.
Crossref
Cora W Hannon, Collette McCourt, Hermenio C Lima, Suephy Chen & Cathy Bennett. (2021) Interventions for cutaneous disease in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Sarah Cipriani, Elisa Maseroli & Linda Vignozzi. 2021. Controversies in Testosterone Deficiency. Controversies in Testosterone Deficiency 81 105 .
Mahnaz Sandoughi, Mahmoud Ali Kaykhaei, Elnaz Langarizadeh & Alireza Dashipour. (2020) Effects of dehydroepiandrosterone on quality of life in premenopausal women with rheumatoid arthritis: A preliminary randomized clinical trial. International Journal of Rheumatic Diseases 23:12, pages 1692-1697.
Crossref
Yuanyuan Li, Jie Ren, Na Li, Jie Liu, Shing Cheng Tan, Teck Yew Low & Zhimin Ma. (2020) A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials. Experimental Gerontology 141, pages 111110.
Crossref
Zara Izadi. (2020) Health‐Related Quality of Life Measures in Adult Systemic Lupus Erythematosus. Arthritis Care & Research 72:S10, pages 577-592.
Crossref
Min Xie, Yanfa Zhong, Qing Xue, Meirong Wu, Xiaoxian Deng, Heitor O. Santos, Shing Cheng Tan, Hamed Kord-Varkaneh & Peng Jiao. (2020) Impact of dehydroepianrosterone (DHEA) supplementation on serum levels of insulin-like growth factor 1 (IGF-1): A dose-response meta-analysis of randomized controlled trials. Experimental Gerontology 136, pages 110949.
Crossref
Jessica M. Jones & Trine N. Jørgensen. (2020) Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus. Frontiers in Immunology 11.
Crossref
L. D. Vorobyeva, E. A. Aseeva, S. K. Solovyev, G. M. Koilubaeva & S. I. Glukhova. (2019) IMPACT OF THERAPY ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (ACCORDING TO THE RENAISSANCE REGISTER). Rheumatology Science and Practice 57:4, pages 421-425.
Crossref
Zahi Touma & Murray B. Urowitz. 2019. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 598 605 .
Melanie R. Gubbels Bupp & Trine N. Jorgensen. (2018) Androgen-Induced Immunosuppression. Frontiers in Immunology 9.
Crossref
Andrew Kwan, Vibeke Strand & Zahi Touma. (2017) The Role of Patient-Reported Outcomes in Systemic Lupus Erythematosus. Current Treatment Options in Rheumatology 3:4, pages 308-321.
Crossref
Tom MunyerBhavyata Parag & William Towers. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Y Björk, E Smith Knutsson, C Ankarberg-Lindgren, A-K Broman, I Andersson, L Björkman, J Magnusson, K Bergmark, H Anderson, P-O Andersson & M Brune. (2016) Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy. Bone Marrow Transplantation 52:3, pages 431-437.
Crossref
L. Durcan & M. Petri. (2016) Immunomodulators in SLE: Clinical evidence and immunologic actions. Journal of Autoimmunity 74, pages 73-84.
Crossref
Michelle Petri, Ariane K. Kawata, Ancilla W. Fernandes, Kavita Gajria, Warren Greth, Asha Hareendran & Dominique Ethgen. (2013) Impaired Health Status and the Effect of Pain and Fatigue on Functioning in Clinical Trial Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology 40:11, pages 1865-1874.
Crossref
A. N. Kiani, V. Strand, H. Fang, J. Jaranilla & M. Petri. (2013) Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology 52:9, pages 1651-1657.
Crossref
A. Schmeding & M. Schneider. (2013) Fatigue, health-related quality of life and other patient-reported outcomes in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 27:3, pages 363-375.
Crossref
Daniel J. Wallace. 2013. Dubois' Lupus Erythematosus and Related Syndromes. Dubois' Lupus Erythematosus and Related Syndromes 626 632.e12 .
Anna C. Phillips, Riyad Khanfer & Jane Upton. 2013. Immunosenescence. Immunosenescence 47 62 .
CL Overman, A Hartkamp, ER Bossema, M Bijl, GLR Godaert, JWJ Bijlsma, RHWM Derksen & R Geenen. (2012) Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate. Lupus 21:14, pages 1515-1521.
Crossref
David J. Handelsman. 2012. Testosterone. Testosterone 372 407 .
Abdulmaged M. Traish, H. Paco Kang, Farid Saad & Andre T. Guay. (2011) Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME). The Journal of Sexual Medicine 8:11, pages 2960-2982.
Crossref
Chian-Jiun Liou & Wen-Chung Huang. (2011) Dehydroepiandrosterone Suppresses Eosinophil Infiltration and Airway Hyperresponsiveness via Modulation of Chemokines and Th2 Cytokines in Ovalbumin-Sensitized Mice. Journal of Clinical Immunology 31:4, pages 656-665.
Crossref
Anan J. Haija & Steffan W. Schulz. (2011) The Role and Effect of Complementary and Alternative Medicine in Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 37:1, pages 47-62.
Crossref
Michelle J. Ormseth & John S. Sergent. (2010) Adrenal Disorders in Rheumatology. Rheumatic Disease Clinics of North America 36:4, pages 701-712.
Crossref
W. MarderEC Somers, MJ Kaplan, MR Anderson, EE Lewis & WJ McCune. (2010) Effects of Prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study. Lupus 19:10, pages 1229-1236.
Crossref
Adnan N. Kiani & Michelle Petri. (2010) Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus. Current Rheumatology Reports 12:4, pages 250-258.
Crossref
Jinoos Yazdany & Edward Yelin. (2010) Health-Related Quality of Life and Employment Among Persons with Systemic Lupus Erythematosus. Rheumatic Disease Clinics of North America 36:1, pages 15-32.
Crossref
Fernand Labrie. 2010. Neuroendocrinology - Pathological Situations and Diseases. Neuroendocrinology - Pathological Situations and Diseases 97 148 .
Helena Forsblad-d'Elia, Hans Carlsten, Fernand Labrie, Yrjö T. Konttinen & Claes Ohlsson. (2009) Low Serum Levels of Sex Steroids Are Associated with Disease Characteristics in Primary Sjogren’s Syndrome; Supplementation with Dehydroepiandrosterone Restores the Concentrations. The Journal of Clinical Endocrinology & Metabolism 94:6, pages 2044-2051.
Crossref
Karin Franck-Larsson, Wilhelm Graf & Anders Rönnblom. (2009) Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: a population-based study. European Journal of Gastroenterology & Hepatology 21:2, pages 176-182.
Crossref
Nicole Maninger, Owen M. Wolkowitz, Victor I. Reus, Elissa S. Epel & Synthia H. Mellon. (2009) Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Frontiers in Neuroendocrinology 30:1, pages 65-91.
Crossref
Amr H. Sawalha & Susan Kovats. (2008) Dehydroepiandrosterone in systemic lupus erythematosus. Current Rheumatology Reports 10:4, pages 286-291.
Crossref
S. Y. Yuen & J. E. Pope. (2008) Learning from past mistakes: assessing trial quality, power and eligibility in non-renal systemic lupus erythematosus randomized controlled trials. Rheumatology 47:9, pages 1367-1372.
Crossref
Michael S. Ritsner. 2008. Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders. Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders 337 368 .
Vibeke Strand. (2007) A novel means to demonstrate early efficacy of a product in systemic lupus erythematosus. Current Rheumatology Reports 9:6, pages 427-430.
Crossref
David Crosbie, Corri Black, Linda McIntyre, Pamela Royle & Sian Thomas. (2007) Dehydroepiandrosterone for systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2010:1.
Crossref
B. Allolio, W. Arlt & S. Hahner. (2007) DHEA: why, when, and how much – DHEA replacement in adrenal insufficiency. Annales d'Endocrinologie 68:4, pages 268-273.
Crossref
Julian Thumboo & Vibeke Strand. (2007) Health-related Quality of Life in Patients with Systemic Lupus Erythematosus: An Update. Annals of the Academy of Medicine, Singapore 36:2, pages 115-122.
Crossref
K Mcelhone, J Abbott & L -S Teh. (2016) A review of health related quality of life in systemic lupus erythematosus. Lupus 15:10, pages 633-643.
Crossref
Wiebke Arlt. (2006) Dehydroepiandrosterone replacement therapy. Current Opinion in Endocrinology and Diabetes 13:3, pages 291-305.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.